Implementing International Standards of Practice in A Low Resource Country by Blended Training Modules to Improve Stroke Care

NCT ID: NCT04995146

Last Updated: 2021-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Lack of proper stroke care delivery leads to poor patient outcomes in middle- and low-income countries that can be improved by implementation of international standards. We aim to determine feasibility of implementing stroke core measures and training through blended learning modules in resource poor countries to improve stroke outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Lack of proper stroke care delivery leads to poor patient outcomes in middle- and low-income countries that can be improved by implementation of international standards. We aim to determine feasibility of implementing stroke core measures and training through blended learning modules in resource poor countries to improve stroke outcomes.

Methods: The project will be conducted across four hospitals in Pakistan in three phases. First stage will include retrospective collection of data for the preceding 4 weeks from start. In stage II, 3 months data will be collected before implementation of core measures. The stepwise training of staff will begin simultaneously, and data will continue to be collected. In stage III by the end of 3 months of stage II, core measures will be implemented as standard of care and patients will be enrolled for another 3 months. Outcomes measures will be successful implementation of the stroke care model as measured by survey done at the end and patient outcomes including in-hospital complication rates, length of hospital stay, patient and caregiver education, mRS at 3 months after discharge, post discharge complications and re-stroke rate. Data will be compared against published data from Pakistan and between patients in the first and last 3 months of the project. Statistical analyses will include appropriate mixed-effects multivariate regression models (i.e., linear and logistic) to model the relationship between clinical measures and patient safety. Degree of correlation across each symptom predictor will be measured. This study will not involve thrombolytic therapy or thrombectomy. However, the study will not provide any hindrance to implementation of such therapy and will not include such patients in analysis.

Discussion: At least one third of stroke survivors in Pakistan die due to recurrent vascular events and complications of stroke in absence of core measures. Prevention practices and stroke care are significantly underutilized in low- and middle-income countries but can be improved most efficiently by improving care delivering process without additional burden on resources by following American Heart Association "Get With The Guidelines" Stroke (GWTG-Stroke) program, Royal College of Physicians UK and European Guidelines, regardless of thrombolysis or thrombectomy. This feasibility study aims to develop a multidisciplinary comprehensive stroke team model with gradual integration of staff training, nursing care, therapy and patient education.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Retrospective 3 months cohort (admitted stroke patients)

Clinical stroke extended management pathway

Intervention Type OTHER

1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS

Prospective pre-implementation "standard of core care quality measures" cohort

Clinical stroke extended management pathway

Intervention Type OTHER

1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS

Prospective post-implementation "standard of core care quality measures" cohort

Clinical stroke extended management pathway

Intervention Type OTHER

1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical stroke extended management pathway

1. Extracranial imaging
2. ECG in 2-7 days
3. DVT prophylaxis
4. Stroke educational material for patient and family Removal of Foley's catheter and start bladder management
5. Discharged on: Antithrombotic therapy OR Anticoagulation therapy▸ Antihypertensives ▸ Statins/cholesterol lower agent ▸ Antidiabetic agent
6. Fasting lipid profile, HbA1c
7. Holter monitor
8. Specialized workup for young stroke
9. PFO Study, MES Study
10. Referral to: ▸ Rehabilitation specialist ▸ Speech therapist ▸ Dietician ▸ Occupational therapist ▸ Medical team
11. Follow-up: CTA, CT angiography; HbA1c, glycated haemoglobin; MRA, MR angiography
12. Follow-up plan and 90 day mRS

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Acute onset of Symptoms in the last 24 hours suggestive of stroke Age \> 18 years Ischemic or hemorrhagic stroke

\-

Exclusion Criteria

Presenting after 24 hours of onset of symptoms Alternate explanation for presenting symptoms (stroke mimics) Family (Surrogate Decision Maker) or next of kin/ patient refusal for participation Transfer of care from another department or hospital Care needed in another department (e.g, ICU, other department) GCS (Glasgow Coma Scale) below 5 or End of life care initiated TIA (Transient Ischemic Attack)

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fauji Foundation Hospital

Rawalpindi, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2020/8

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nutritional Therapy for Stroke Patients
NCT00163007 COMPLETED PHASE2/PHASE3